This independence indicates that ADAMTS7 may serve as a specific marker for invasive behavior in GC, without being influenced by broader patient characteristics or disease stage, highlighting its potential clinical significance in assessing tumor aggressiveness. The gene discussed is ADAMTS7; the disease is neoplasm.